Algert Global LLC Acquires 51,006 Shares of Phreesia, Inc. (NYSE:PHR)

Algert Global LLC lifted its holdings in shares of Phreesia, Inc. (NYSE:PHR - Free Report) by 190.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 77,833 shares of the company's stock after acquiring an additional 51,006 shares during the quarter. Algert Global LLC owned 0.13% of Phreesia worth $1,958,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Johnson Financial Group Inc. raised its stake in shares of Phreesia by 381.3% during the 4th quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company's stock worth $28,000 after purchasing an additional 896 shares during the period. R Squared Ltd purchased a new stake in Phreesia during the fourth quarter worth about $30,000. BankPlus Trust Department bought a new stake in Phreesia in the fourth quarter worth about $34,000. Quarry LP boosted its stake in Phreesia by 210.9% in the fourth quarter. Quarry LP now owns 2,835 shares of the company's stock valued at $71,000 after acquiring an additional 1,923 shares during the last quarter. Finally, Venturi Wealth Management LLC purchased a new position in Phreesia in the fourth quarter valued at about $76,000. Hedge funds and other institutional investors own 92.10% of the company's stock.

Insider Buying and Selling

In other Phreesia news, General Counsel Allison C. Hoffman sold 1,213 shares of the firm's stock in a transaction dated Wednesday, April 16th. The stock was sold at an average price of $23.81, for a total value of $28,881.53. Following the sale, the general counsel now owns 137,921 shares of the company's stock, valued at $3,283,899.01. This trade represents a 0.87 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Yvonne Hui sold 1,878 shares of the business's stock in a transaction dated Tuesday, April 8th. The stock was sold at an average price of $23.85, for a total value of $44,790.30. Following the transaction, the insider now directly owns 28,449 shares of the company's stock, valued at $678,508.65. The trade was a 6.19 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 111,640 shares of company stock worth $3,094,167. Corporate insiders own 5.80% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on the company. DA Davidson dropped their price objective on Phreesia from $36.00 to $34.00 and set a "buy" rating on the stock in a research note on Monday, April 14th. KeyCorp dropped their price target on Phreesia from $30.00 to $28.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 16th. Canaccord Genuity Group lifted their price objective on Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a report on Thursday, March 13th. Piper Sandler restated an "overweight" rating and issued a $33.00 price objective (up from $31.00) on shares of Phreesia in a research note on Wednesday, January 29th. Finally, Needham & Company LLC reiterated a "buy" rating and set a $29.00 target price on shares of Phreesia in a research report on Thursday, March 13th. Twelve equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company presently has a consensus rating of "Buy" and an average price target of $31.33.

Phreesia Price Performance

Phreesia stock traded up $0.19 during midday trading on Friday, reaching $25.57. 867,739 shares of the stock were exchanged, compared to its average volume of 435,606. The company's fifty day moving average is $25.08 and its 200-day moving average is $24.72. The firm has a market cap of $1.50 billion, a PE ratio of -17.39 and a beta of 0.74. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74. Phreesia, Inc. has a 52 week low of $17.07 and a 52 week high of $30.53.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.